This video summarizes a conversation between Dr. Andrew Huberman — Stanford professor of neurobiology and ophthalmology and host of the Huberman Lab podcast — and Daisy Wolf. They take a deep dive into the backdrop of the post-pandemic consumer health revolution, the current state of emerging peptides and GLP-1 drugs, the science behind focus-enhancing substances, and the neurotechnology that Dr. Huberman believes will allow us to regulate our biological functions within five years. They also offer fascinating insights into AI and animal intelligence, and explore the direction of future healthcare.

1. The Health Awakening and the Impact of the Pandemic

Dr. Andrew Huberman explains that the pandemic is the primary reason consumer interest in health exploded over the past five years. Previously, he thought people only wanted to spend money on appearance or sexual function drugs (e.g., Propecia, Viagra), but the pandemic made people realize that they themselves are responsible for their own health.

"The one very clear thing that everyone realized was that the bell had rung: 'We are all responsible for our own health.'"

Dr. Huberman diagnoses this shift as not merely a trend, but as something that began with the emergence of a few groundbreaking supplements and changes in the fitness industry. In the past, only bodybuilders and athletes did strength training, but from the eighties through the early 2000s, exercise gradually came to be accepted as part of a healthy, normal life.

During the pandemic in particular, everyone — regardless of vaccination status — became interested in boosting immunity, and it was then that vitamin D first entered the mainstream spotlight. Subsequently, melatonin, protein supplements, and creatine gained popularity as health aids, and people became increasingly inclined to manage their own health. The pandemic reminded people of their own mortality and instilled the understanding that annual checkups alone cannot guarantee health.

"COVID-19 reminded people of their own mortality, and they realized that getting an annual physical from a doctor didn't mean they were healthy, protected, or safe."

Dr. Huberman emphasizes that the spike in mental health problems during the pandemic lockdowns was closely linked to disruption of circadian rhythms. A study of more than 80,000 people in the UK found that the brighter the days and the darker the nights, the better mental health outcomes were. He notes that this held true for nearly all psychiatric conditions, including OCD, anxiety, mania, schizophrenia, and major depression.

Dr. Huberman mentions that through his podcast he provided useful, science-based information — such as techniques for regulating circadian rhythms and using extended exhalation breathing to reduce momentary anxiety.

2. MAHA and the Role of the Health Movement

Dr. Huberman touches on the role of MAHA (an acronym inspired by the Biden-Harris Administration's White House Conference on Hunger, Nutrition, and Health), explaining that he chose not to join the MAHA panel in order to speak his beliefs freely. He believes MAHA's direction — improving the food supply and encouraging healthy behaviors — is correct, but says he needs to be able to take a critical stance on specific issues as well.

For example, he believes mRNA vaccines for cancer treatment are transformational, life-saving technology, and expresses concern that funding for related research was cut. However, he notes that a Washington insider clarified that funding for mRNA vaccines for respiratory diseases had been cut, not for cancer treatment, and points out that there was miscommunication in how this information was conveyed.

Dr. Huberman identifies the current polarized media environment as a problem. He explains that both left-wing and right-wing media refuse to report anything positive about the opposing side and only highlight criticism, which affects clicks and ad revenue. He argues that this tendency is especially damaging to the entire health space.

"I think the bar for what gets treated as news has actually fallen. Honestly, it saddens me, because it degrades the entire health space."

While it's easy to blame health influencers or biohackers for polluting this space, he argues that traditional media bears greater responsibility. For example, when new dietary guidelines were released, media reported them as if they excessively encouraged meat consumption, when in fact the recommended intake of grains, fruits, and vegetables was equally high.

Dr. Huberman emphasizes how important it is to him to speak his mind freely without belonging to any particular camp. He says he will support people taking initiative for their own health (e.g., managing circadian rhythms, reducing anxiety, improving sleep, eating clean food, increasing physical activity), as these efforts are vitally important.

3. The GLP-1 Drug and Peptide Craze

Dr. Huberman notes that one in seven Americans is currently taking a GLP-1 drug, and 20% have tried one at some point, reflecting how popular these drugs have become. He explains that new drugs like Retatrutide (GLP-3) currently in development at Eli Lilly showed clinical Phase 3 results of reducing body weight by up to one-third, and appear to bypass some of the side effects of existing GLP-1 drugs. He predicts that GLP-1 drugs have the potential to eradicate obesity.

"Theoretically, you could eradicate obesity."

He expects that within five years, more than half of Americans will be taking GLP-1 drugs. He adds that people with a genetic predisposition to obesity are particularly likely to take low doses. Interestingly, many people are obtaining cheaper GLP-1 drugs through compounding pharmacies or the gray market, or conducting "rogue experiments" with lower doses. While not strictly legal, he notes that no serious adverse events have been reported so far, so regulatory enforcement has been minimal.

Dr. Huberman shows interest in other peptides as well.

• BPC-157 (Body Protection Compound): Animal studies have shown effects promoting cartilage growth, nerve regeneration, and vascular growth. However, he emphasizes that caution is needed because vascular growth may be associated with tumor growth.
• Melanotan: Said to tan the skin and dramatically increase energy and libido while also reducing fat. He warns it is a very dangerous drug due to risks of serious side effects such as permanent skin color changes and priapism in men.
• Pinealin (Pineal gland secretagogue): A peptide that aids sleep; Dr. Huberman mentions he tried it himself and experienced three hours of REM sleep at night. However, he says he no longer takes it due to concerns that it may cause tumors by inducing excessive proliferation of pineal gland cells.

Dr. Huberman explains that while the term "peptide" is used to refer to a specific class of peptides, hormones like insulin are also peptides. He categorizes the channels through which peptides can be purchased and explains the associated risks:

1. Pharmaceutical companies: Follow the strictest standards but are expensive.
2. Compounding pharmacies: Cheaper than pharmaceutical companies but less regulated.
3. Gray market: Sold with disclaimers such as "for research purposes only, not for human use," but in practice many people take them. He notes concern that while they are mostly purified to 99% purity, 1% contaminants like lipopolysaccharides can cause inflammation.
4. Black market (especially "Chinese peptides"): The most dangerous; there is no way to know the actual ingredients, so safety cannot be guaranteed.

He mentions finding it interesting that GLP-1 drugs are being explored beyond simple weight loss for uses such as reducing alcohol cravings and reducing cognitive noise.

4. Focus-Enhancing Drugs and the Future of Neurotechnology

Dr. Huberman addresses the current discourse around focus-enhancing drugs, explaining that drugs like modafinil and Adderall are used to treat excessive daytime sleepiness or ADHD, but in reality they increase alertness to enable focus rather than directly enhancing focus itself. Interestingly, recent research from the University of Washington found that stimulants like Adderall improve focus as much as getting sufficient sleep.

He also mentions Sunosi, an FDA-approved drug he expects will become more widespread. Approved for excessive daytime sleepiness, it also showed good results in ADHD clinical trials, and acts on serotonin in addition to dopamine and norepinephrine, providing a smoother alertness and focus effect. Dr. Huberman says he tried Sunosi himself but found it too strong and returned to caffeine.

He notes that various stimulants such as Wellbutrin and nicotine are being used for focus enhancement, and expresses concern that stimulant overuse is at a serious level.

"I think stimulant use is excessive. And this is coming from someone who drinks a lot of caffeine, who honestly wants a drug that will boost my focus, but you always pay the price with sleep or cardiac issues. I don't want to over-stimulate the sympathetic nervous system too much, too often. It's probably going to shorten your life."

Dr. Huberman predicts that future healthcare will evolve into the forms of "reading" and "writing".

• Reading: Currently we are at the stage of measuring biological signals through sleep sensors, continuous glucose monitors (CGMs), and the like. However, he expects that within five years, real-time cortisol measurement technology will emerge to help people maintain the healthy pattern of high cortisol in the morning and low in the afternoon.
• Writing: This refers to technology that directly regulates bodily functions based on measured biological signals. For example, he says technology will be developed where a small device attached to the palms or feet before sleep lowers body temperature to induce sleep, and a sleep mask emitting 10,000 lux of light in the morning aids waking. He emphasizes that these compact devices applied directly to the body will be far more efficient than today's macro-level environmental controls (e.g., cooling an entire room).

"Five years from now we're going to look back and say, 'Oh my God, we were cooling the whole room in order to fall asleep?'"

He expects that "writing" technology for the human body will see significant advances particularly in the field of sleep regulation. He also thinks that precisely manipulating the brain and nervous system to finely regulate cognitive states will be the "holy grail" of the future. He doesn't believe brain implant technology (e.g., Neuralink) will achieve complex goals like doubling memory in the short term, but predicts that glasses-like devices capable of maximizing focus for a specific period through external stimulation will arrive soon.

"For 40 minutes you will experience the kind of focus you've only had a few times when all conditions were perfect. Work for 40 minutes, hit the done button, take them off, and go do something else."

He sees great potential in technology that regulates brain states through the eyes, ears, and peripheral surface nerves, and says that if he were investing, he would focus on this area.

5. AI and Longevity, and Communicating with Octopuses

Dr. Huberman acknowledges the possibility that his role could be replaced as AI becomes skilled at explaining complex health information in accessible ways. He mentions that he actually uses AI like Claude to test his own knowledge. However, he emphasizes that beyond simply presenting information, the way information is delivered has a decisive impact on people's behavior change.

"Why don't people just do those things? I think there's something about the human brain that means the likelihood of us accepting a protocol or changing a behavior — while it depends enormously on the efficacy of that behavior — depends greatly on how we learn the information."

He explains that people are more likely to act on advice when they understand the mechanism, which can even change how the protocol itself works. For example, understanding that sunlight is a system that is summed by the number of photons reaching the retina means that if you miss sunlight one day, you have the flexibility to make it up with double the next day.

On the question of longevity, Dr. Huberman assesses the concept of "longevity escape velocity" as closer to fantasy than reality. He thinks the genetic ceiling for human lifespan is around 120 years, with most people reaching about 105. Therefore, he says that aiming to live healthily to 100 is a realistic goal.

"Aim for 100. That's my mantra. Just aim to be healthy at 100. I think it's achievable."

He expresses great interest in the research of Tony Wyss-Coray at Stanford University. That research addresses how certain elements found in young blood or post-exercise blood can rejuvenate the brain and body. He emphasizes that ethical questions must come first, of course. Dr. Huberman imagines that in the future, a primitive but useful technique may emerge where you store blood drawn after your own workout and receive it as a transfusion later.

Finally, Dr. Huberman shares a story about his pet octopus "Van Gogh." He thinks octopuses are highly intelligent creatures and says he is researching ways to communicate with them using AI. The goal is to have AI learn the octopus's camouflage patterns and behaviors in order to understand what it is thinking, and ultimately enable communication between humans and octopuses.

"I'm interested in what the octopus understands about the world and can convey to me, because I don't know what that is. I can play piano. Why would I want to teach an octopus to play piano?"

He emphasizes that he is more interested in learning how animals themselves understand the world than in humans' obsession with training other animals to behave like humans. He adds that through new technology and communication with other living beings, he is exploring new territory that can transcend the current "saturation point" of health information, and the conversation concludes on that note.

Conclusion

The conversation with Dr. Huberman clearly illustrates how important individual responsibility for personal health management has become amid the rapidly changing health paradigm following the pandemic. The emergence of GLP-1 drugs and various peptides — along with the resulting expansion of gray markets — suggests that the opportunities new medical technologies bring must be accompanied by careful consideration of safety and ethical concerns. His prediction that the future will move beyond biological data "reading" technology toward "writing" technology that can precisely regulate human biological rhythms such as sleep and focus paints a picture of revolutionary future healthcare. Ultimately, he offers deep insights into the essence of health information delivery through AI, a realistic perspective on human longevity, and even the new frontier of communicating with animals — illuminating how science and technology can expand human life and understanding. 💡